<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="brief-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Clin Invest</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Clin. Invest</journal-id>
<journal-id journal-id-type="publisher-id">J Clin Invest</journal-id>
<journal-title-group>
<journal-title>The Journal of Clinical Investigation</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9738</issn>
<issn pub-type="epub">1558-8238</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31503547</article-id>
<article-id pub-id-type="pmc">6877312</article-id>
<article-id pub-id-type="publisher-id">130419</article-id>
<article-id pub-id-type="doi">10.1172/JCI130419</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Concise Communication</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome model mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6846-5563</contrib-id>
<name>
<surname>Gu</surname>
<given-names>Bin</given-names>
</name>
<email>bin_gu@med.unc.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Manhua</given-names>
</name>
<email>mhzhu@email.unc.edu</email>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Glass</surname>
<given-names>Madison R.</given-names>
</name>
<email>roseg@email.unc.edu</email>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5797-7515</contrib-id>
<name>
<surname>Rougié</surname>
<given-names>Marie</given-names>
</name>
<email>marie.rougie@gmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nikolova</surname>
<given-names>Viktoriya D.</given-names>
</name>
<email>viktoriya_nikolova@med.unc.edu</email>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moy</surname>
<given-names>Sheryl S.</given-names>
</name>
<email>sheryl_moy@med.unc.edu</email>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6248-1493</contrib-id>
<name>
<surname>Carney</surname>
<given-names>Paul R.</given-names>
</name>
<email>paul.carney1@gmail.com</email>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2746-9143</contrib-id>
<name>
<surname>Philpot</surname>
<given-names>Benjamin D.</given-names>
</name>
<email>bphilpot@med.unc.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Cell Biology and Physiology,</aff>
<aff id="A2"><label>2</label>Neuroscience Center,</aff>
<aff id="A3"><label>3</label>Neuroscience Curriculum,</aff>
<aff id="A4"><label>4</label>Department of Psychiatry,</aff>
<aff id="A5"><label>5</label>Carolina Institute for Developmental Disabilities,</aff>
<aff id="A6"><label>6</label>Department of Neurology, and</aff>
<aff id="A7"><label>7</label>Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, USA.</aff>
<author-notes>
<corresp>Address correspondence to: Ben Philpot, University of North Carolina, 116 Manning Drive, CB 7545, Chapel Hill, North Carolina 27599, USA. Phone: 919.966.0025; Email: <email>bphilpot@med.unc.edu</email>.</corresp>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest:</bold> The authors have declared that no conflict of interest exists.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2019-11-04T16:00:00-0500" publication-format="electronic">
<day>4</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date date-type="collection" iso-8601-date="2019-11-04T16:00:00-0500" publication-format="electronic">
<day>4</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date date-type="pub" iso-8601-date="2019-12-02T16:00:00-0500" publication-format="print">
<day>2</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>2</day>
<month>3</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 3 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>129</volume>
<issue>12</issue>
<fpage>5462</fpage>
<lpage>5467</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>3</day>
<month>9</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 American Society for Clinical Investigation</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://www.jci.org/articles/view/130419">This article is available online at https://www.jci.org/articles/view/130419</self-uri>
<abstract>
<p>Angelman syndrome (AS) is a neurodevelopmental disorder characterized by intellectual disability, lack of speech, ataxia, EEG abnormalities, and epilepsy. Seizures in individuals with AS are common, debilitating, and often drug resistant. Thus, there is an unmet need for better treatment options. Cannabidiol (CBD), a major phytocannabinoid constituent of cannabis, has shown antiseizure activity and behavioral benefits in preclinical and clinical studies for some disorders associated with epilepsy, suggesting that the same could be true for AS. Here, we show that acute CBD (100 mg/kg) treatment attenuated hyperthermia- and acoustically induced seizures in a mouse model of AS. However, neither acute CBD nor a 2-week-long course of CBD administered immediately after a kindling protocol could halt the proepileptogenic plasticity observed in AS model mice. CBD had a dose-dependent sedative effect but did not have an impact on motor performance. CBD abrogated the enhanced intracortical local field potential power, including the delta and theta rhythms observed in AS model mice, indicating that CBD administration could also help normalize the EEG deficits observed in individuals with AS. We believe our results provide critical preclinical evidence supporting CBD treatment of seizures and alleviation of EEG abnormalities in AS and will thus help guide the rational development of CBD as a treatment for AS.</p>
</abstract>
<abstract abstract-type="graphical">
<p>
<graphic orientation="portrait" position="float" xlink:href="jci-129-130419-g224.jpg"></graphic>
</p>
</abstract>
<kwd-group kwd-group-type="specialties">
<kwd>Neuroscience</kwd>
</kwd-group>
<kwd-group kwd-group-type="keywords">
<kwd>Epilepsy</kwd>
<kwd>Pharmacology</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Angelman Syndrome Foundation</funding-source>
<award-id>Research grant</award-id>
</award-group>
<award-group>
<funding-source>NIH</funding-source>
<award-id>R01HD093771</award-id>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution>
<institution-id>https://doi.org/10.13039/100009633</institution-id>
</institution-wrap>
</funding-source>
<award-id>HD079124</award-id>
</award-group>
<funding-statement>NICHD U54 Intellectual and Developmental Disabilities Research Center</funding-statement>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>